Autism Spectrum Disorder Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Children who have been diagnosed with Autism Spectrum Disorder (ASD) based on a recognised assessment tool, a standard diagnostic guide (DSM-5), and evaluation by a specialist on the study team
- Children who show delays in communication, specifically scoring below a certain level on tests measuring how they express themselves or understand language
- Children who score above a certain level on tests of non-verbal thinking and fine motor skills (such as visual problem-solving and hand movements)
- Children who were born between 36 and 42 weeks of pregnancy (not significantly premature)
- Children who were born weighing more than 2,500 grams (about 5.5 pounds)
- Children who do not have an identified neurological condition (such as epilepsy), a genetic condition (such as Down syndrome, Fragile X, tuberous sclerosis, or neurofibromatosis), or a severe physical condition affecting movement (such as cerebral palsy)
- Children who are able to walk on their own without assistance
- Children whose parents or carers can confirm, through an eligibility interview, that the child produces at least three different types of intentional communication acts per day — such as making eye contact, using gestures, or vocalising with purpose
Who may not be able to join:
- Children whose primary language spoken at home is not English
- Families who live more than 40 miles away from a Kennedy Krieger Institute CASSI trial site
- Children who are currently living in foster care
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Rebecca Landa, PhD, Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Phone: 443-923-7591
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Child Duration of Joint Attention; Parent Fidelity of Implementation
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.